Case Study: The Company with a New Pharmaceutical Model and Different Accounting
Class Discussion Forum 2 Unit 2 – Case 2.8 – p.78
Note: For the posting style of this forum, you will first post your answer, then you will see other students’ posts to which you can reply. (It may take up to 1/2 hour for the system to post your response and open up the others’ for you to view.)
Background: To prepare for this Class Discussion Forum, review Case 2.8 Valeant: The Company with a New Pharmaceutical Model (p.78)
Participation: To earn points for this Class Discussion Forum, you are to answer the question(s) provided (must use and cite sources) and reply to at least two other student’s answers. In your reply posts, please address the student by name, then give your comment. Your replies to other students’ answers should provide helpful ideas for the class to learn about the topic. Internet sources (using in-text A.P.A. citing) ARE required for this Class Discussion Forum.
- What issues did Valeant miss in its decision on accounting practices and pricing of its drugs?
- Why is transparency an issue for publicly traded companies?
- What credo ideas do you learn from this case?
apa 600 words